Viral Therapy in Treating Patients With Metastatic Melanoma

Completed · Phase 2

Conditions studied: Recurrent Melanoma, Stage IV Melanoma

In brief

This phase II trial is studying the side effects and how well viral therapy works in treating patients with metastatic melanoma. Viral therapy may be able to kill tumor cells without damaging normal cells.

Key facts

Study ID
NCT00651157
Run by
National Cancer Institute (NCI)
People needed
23
Starts
2008-04-01
Expected to finish
2012-10-01
Last updated by the study team
2014-04-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.